Legal & General Group Plc Acquires Shares of 48,140 Calumet, Inc. $CLMT

Legal & General Group Plc acquired a new stake in Calumet, Inc. (NASDAQ:CLMT) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 48,140 shares of the oil and gas company’s stock, valued at approximately $1,734,000.

A number of other hedge funds have also modified their holdings of CLMT. Islay Capital Management LLC acquired a new position in shares of Calumet in the 4th quarter worth approximately $25,000. Aster Capital Management DIFC Ltd grew its position in Calumet by 294.7% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after acquiring an additional 1,229 shares during the period. Global Retirement Partners LLC acquired a new position in Calumet during the fourth quarter worth $34,000. Covestor Ltd raised its stake in Calumet by 29.1% during the fourth quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock worth $43,000 after acquiring an additional 492 shares in the last quarter. Finally, Advisory Services Network LLC bought a new position in shares of Calumet during the third quarter valued at $59,000. 34.41% of the stock is owned by institutional investors and hedge funds.

Calumet Price Performance

Shares of NASDAQ:CLMT opened at $53.13 on Monday. The firm has a market cap of $4.67 billion, a P/E ratio of -34.28 and a beta of 0.72. Calumet, Inc. has a 12 month low of $16.75 and a 12 month high of $54.69. The company’s 50-day moving average price is $43.76 and its two-hundred day moving average price is $36.26.

Calumet (NASDAQ:CLMT) last announced its earnings results on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($1.16). The business had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.12 billion. During the same period in the previous year, the company posted ($1.70) earnings per share. The company’s revenue was up 40.8% on a year-over-year basis. As a group, equities analysts predict that Calumet, Inc. will post 0.48 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Daniel Sajkowski sold 4,240 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $36.16, for a total value of $153,318.40. Following the completion of the transaction, the director owned 77,718 shares in the company, valued at $2,810,282.88. The trade was a 5.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 3.15% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CLMT. HC Wainwright boosted their target price on shares of Calumet from $60.00 to $75.00 and gave the company a “buy” rating in a research note on Wednesday, September 2nd. TD Cowen increased their target price on shares of Calumet from $34.00 to $40.00 and gave the stock a “hold” rating in a research report on Wednesday, August 12th. UBS Group lifted their price target on shares of Calumet from $26.00 to $47.00 and gave the company a “neutral” rating in a report on Tuesday, August 25th. Citigroup restated a “buy” rating on shares of Calumet in a research report on Monday, August 10th. Finally, The Goldman Sachs Group upped their price objective on shares of Calumet from $40.00 to $45.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 18th. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $51.75.

Key Headlines Impacting Calumet

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright raised its earnings forecasts and maintained a Buy rating. The firm increased its Q3 2026 EPS estimate to $0.62 from $0.60, Q4 to $0.24 from $0.22, FY2026 to $0.17 from $0.12, and FY2027 to $1.11 from $0.59. Its $75 price target implies substantial upside from the stock’s recent trading level. HC Wainwright earnings estimate report
• Positive Sentiment: The upward revisions suggest HC Wainwright expects stronger profitability over the next several quarters, potentially reflecting improved operating performance or business conditions. The revised FY2027 forecast is notably above the broader current-year consensus estimate of $0.46 per share. Calumet stock price expected to rise
• Neutral Sentiment: Calumet announced plans to attend the H.C. Wainwright conference. The event could provide investors with updates on strategy and operations, but no new financial information was disclosed in the announcement. Calumet conference announcement
• Neutral Sentiment: A Zacks analysis compared Calumet’s year-to-date performance with TXO Partners and the broader oil-and-energy sector. The article provides relative-performance context but does not indicate a new company-specific catalyst. Zacks Calumet sector performance analysis
• Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of Calumet investors. Although the announcement does not establish wrongdoing, the prospect of litigation or regulatory concerns may weigh on sentiment and introduce uncertainty. Pomerantz investor investigation

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.